Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Middeke

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Blood|March 22, 2014
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantationJan M Middeke, Min Fang, Jan J Cornelissen, et al.
Frontiers in Oncology|April 7, 2022
Point Mutations in the <i>FLT3</i>-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant <i>KMT2A</i>-PTDSebastian Stasik, Michael Kramer, Sven Zukunft, et al.
Blood|March 5, 2017
Somatic <i>TP53</i> mutations characterize preleukemic stem cells in acute myeloid leukemiaRidhima Lal, Karin Lind, Ellen Heitzer, et al.
Frontiers in Immunology|June 25, 2025
Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association studyElke Rücker-Braun, Bose Falk, Henning Baldauf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutationsK Heidrich, C Thiede, K Schäfer-Eckart, et al.
Haematologica|August 26, 2017
Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8<sup>+</sup> cytotoxic T cellsFalk Heidenreich, Elke Rücker-Braun, Juliane S Walz, et al.
Leukemia|February 12, 2011
Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategyS Tuve, J Gayoso, C Scheid, et al.
Leukemia|August 19, 2015
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trialJ M Middeke, R Herbst, S Parmentier, et al.
Blood Cancer Journal|January 16, 2016
Karyotype complexity and prognosis in acute myeloid leukemiaF Stölzel, B Mohr, M Kramer, et al.
British Journal of Haematology|January 16, 2016
TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantationJan M Middeke, Sylvia Herold, Elke Rücker-Braun, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Blood|March 22, 2014
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantationJan M Middeke, Min Fang, Jan J Cornelissen, et al.
Frontiers in Oncology|April 7, 2022
Point Mutations in the <i>FLT3</i>-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant <i>KMT2A</i>-PTDSebastian Stasik, Michael Kramer, Sven Zukunft, et al.
Blood|March 5, 2017
Somatic <i>TP53</i> mutations characterize preleukemic stem cells in acute myeloid leukemiaRidhima Lal, Karin Lind, Ellen Heitzer, et al.
Frontiers in Immunology|June 25, 2025
Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association studyElke Rücker-Braun, Bose Falk, Henning Baldauf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutationsK Heidrich, C Thiede, K Schäfer-Eckart, et al.
Haematologica|August 26, 2017
Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8<sup>+</sup> cytotoxic T cellsFalk Heidenreich, Elke Rücker-Braun, Juliane S Walz, et al.
Leukemia|February 12, 2011
Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategyS Tuve, J Gayoso, C Scheid, et al.
Leukemia|August 19, 2015
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trialJ M Middeke, R Herbst, S Parmentier, et al.
Blood Cancer Journal|January 16, 2016
Karyotype complexity and prognosis in acute myeloid leukemiaF Stölzel, B Mohr, M Kramer, et al.
British Journal of Haematology|January 16, 2016
TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantationJan M Middeke, Sylvia Herold, Elke Rücker-Braun, et al.
Pageof 16